Industrial point source emissions and incident breast and lung cancers: two case–control studies
Cancer Causes & Control · 2026-05 · 37 (5)
DOI: 10.1007/s10552-026-02168-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Causes & Control, online erschienen am 15.04.2026. Verfasst von Joseph Boyle und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Population Health, Virginia Commonwealth University, 830 East Main Street, 6thFloor, Richmond, VA, 23219, USA. boyl…. Hauptthemen laut MEDLINE: Lung Neoplasms, Breast Neoplasms, Environmental Exposure, Air Pollutants. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Purpose
Better understanding of the environment’s role in breast cancer (BC) and lung cancer (LC) incidence is crucial for population health. Growing evidence suggests environmental factors may be relevant for these cancers. We performed two case–control analyses to determine associations between industrial point source emissions, which are proxies for ambient industrial point source-based environmental exposures, and incident BC and LC.
Methods
We obtained information for 5,801 female adults with BC, 5,250 adults with LC, and 47,956 cancer-free adult controls over 2010–2023. We linked individuals’ residences to releases of 11 agents reported to EPA’s Toxics Release Inventory, determining presence and number of facilities and inverse distance-weighted emissions using several geographic buffer distances and lag times. We fit conditional logistic regression models with multiple comparisons adjustments to datasets derived from three matching methods.
Results
We identified positive associations between ethylene oxide and chromium exposures with BC. Associations were consistently positive for presence of ethylene oxide-emitting facilities within 5-20 km and chromium-emitting facilities from 5 to 20 km. We identified positive associations between formaldehyde and chromium exposures with LC. Associations were consistently positive for presence of formaldehyde-emitting facilities within 5–20 km and chromium-emitting facilities from 5 to 20 km.
Conclusion
We observed relationships between industrial point source emissions with BC and LC, particularly for presence of facilities within 5 km of residence. Research should continue examining the role of such emissions for risk of these cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine and Population Health, Virginia Commonwealth University, 830 East Main Street, 6thFloor, Richmond, VA, 23219, USA. boylejr@vcu.edu.
- Massey Comprehensive Cancer Center, Richmond, VA, USA. boylejr@vcu.edu.
- Massey Comprehensive Cancer Center, Richmond, VA, USA.
- Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Surgery, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Family Medicine and Population Health, Virginia Commonwealth University, 830 East Main Street, 6thFloor, Richmond, VA, 23219, USA.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Boyle, J., Nana-Sinkam, P., McGuire, K. P., & Fuemmeler, B. F. (2026). Industrial point source emissions and incident breast and lung cancers: two case–control studies. Cancer Causes & Control, 37(5). https://doi.org/10.1007/s10552-026-02168-7
Vancouver
Boyle J, Nana-Sinkam P, McGuire KP, Fuemmeler BF. Industrial point source emissions and incident breast and lung cancers: two case–control studies. Cancer Causes & Control. 2026;37(5). doi:10.1007/s10552-026-02168-7
BibTeX
@article{Boyle2026,
author = {Boyle, Joseph and Nana-Sinkam, Patrick and McGuire, Kandace P and Fuemmeler, Bernard F},
title = {Industrial point source emissions and incident breast and lung cancers: two case–control studies},
journal = {Cancer Causes & Control},
year = {2026},
volume = {37},
number = {5},
doi = {10.1007/s10552-026-02168-7}
}
EUVIMED